VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 464 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2014. The put-call ratio across all filers is 1.12 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $5,569,000 | +3.6% | 42,408 | 0.0% | 0.15% | +8.1% |
| Q2 2014 | $5,373,000 | +78.0% | 42,408 | +85.2% | 0.14% | +119.4% |
| Q1 2014 | $3,018,000 | +99.3% | 22,900 | +77.5% | 0.06% | +93.8% |
| Q4 2013 | $1,514,000 | +85.8% | 12,900 | +65.4% | 0.03% | +77.8% |
| Q3 2013 | $815,000 | +21.5% | 7,800 | 0.0% | 0.02% | +38.5% |
| Q2 2013 | $671,000 | – | 7,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |